172 related articles for article (PubMed ID: 10983419)
1. Enzyme selectivity of new cyclooxygenase-2/5 lipoxygenase inhibitors using molecular modeling approach.
Kothekar V; Sahi S; Mishra J
Indian J Biochem Biophys; 2000 Apr; 37(2):86-96. PubMed ID: 10983419
[TBL] [Abstract][Full Text] [Related]
2. New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position.
Janusz JM; Young PA; Ridgeway JM; Scherz MW; Enzweiler K; Wu LI; Gan L; Chen J; Kellstein DE; Green SA; Tulich JL; Rosario-Jansen T; Magrisso IJ; Wehmeyer KR; Kuhlenbeck DL; Eichhold TH; Dobson RL
J Med Chem; 1998 Aug; 41(18):3515-29. PubMed ID: 9719605
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
[TBL] [Abstract][Full Text] [Related]
4. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
[TBL] [Abstract][Full Text] [Related]
5. New cyclooxygenase-2/5-lipoxygenase inhibitors. 2. 7-tert-butyl-2,3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations of the dihydrobenzofuran ring.
Janusz JM; Young PA; Scherz MW; Enzweiler K; Wu LI; Gan L; Pikul S; McDow-Dunham KL; Johnson CR; Senanayake CB; Kellstein DE; Green SA; Tulich JL; Rosario-Jansen T; Magrisso IJ; Wehmeyer KR; Kuhlenbeck DL; Eichhold TH; Dobson RL
J Med Chem; 1998 Mar; 41(7):1124-37. PubMed ID: 9544212
[TBL] [Abstract][Full Text] [Related]
6. New cyclooxygenase-2/5-lipoxygenase inhibitors. 1. 7-tert-buty1-2,3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: discovery and variation of the 5-keto substituent.
Janusz JM; Young PA; Ridgeway JM; Scherz MW; Enzweiler K; Wu LI; Gan L; Darolia R; Matthews RS; Hennes D; Kellstein DE; Green SA; Tulich JL; Rosario-Jansen T; Magrisso IJ; Wehmeyer KR; Kuhlenbeck DL; Eichhold TH; Dobson RL; Sirko SP; Farmer RW
J Med Chem; 1998 Mar; 41(7):1112-23. PubMed ID: 9544211
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of N-difluoromethyl-1,2-dihydropyrid-2-one acetic acid regioisomers: dual inhibitors of cyclooxygenases and 5-lipoxygenase.
Yu G; Praveen Rao PN; Chowdhury MA; Abdellatif KR; Dong Y; Das D; Velázquez CA; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2010 Apr; 20(7):2168-73. PubMed ID: 20202839
[TBL] [Abstract][Full Text] [Related]
9. Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition.
Geronikaki AA; Lagunin AA; Hadjipavlou-Litina DI; Eleftheriou PT; Filimonov DA; Poroikov VV; Alam I; Saxena AK
J Med Chem; 2008 Mar; 51(6):1601-9. PubMed ID: 18311898
[TBL] [Abstract][Full Text] [Related]
10. Syntheses and characterization of nimesulide derivatives for dual enzyme inhibitors of both cyclooxygenase-1/2 and 5-lipoxygenase.
Li Y; Chen SH; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
Bioorg Med Chem; 2011 Mar; 19(6):2074-83. PubMed ID: 21349729
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production.
Chen CS; Tan CM; Huang CH; Chang LC; Wang JP; Cheng FC; Chern JW
Bioorg Med Chem; 2010 Jan; 18(2):597-604. PubMed ID: 20056549
[TBL] [Abstract][Full Text] [Related]
12. COX, LOX and platelet aggregation inhibitory properties of Lauraceae neolignans.
Coy ED; Cuca LE; Sefkow M
Bioorg Med Chem Lett; 2009 Dec; 19(24):6922-5. PubMed ID: 19880317
[TBL] [Abstract][Full Text] [Related]
13. [Studied on docking of 5,6-diaryl-2,3-dihydro-1-pyrrolizinone derivatives with cyclooxygenase].
Zhao LQ; Hu YD; Yuan Y; Zhang T; Zhang SF; Li S
Yao Xue Xue Bao; 2001 Jun; 36(6):415-8. PubMed ID: 12585123
[TBL] [Abstract][Full Text] [Related]
14. New COX-2/5-LOX inhibitors: apoptosis-inducing agents potentially useful in prostate cancer chemotherapy.
Pommery N; Taverne T; Telliez A; Goossens L; Charlier C; Pommery J; Goossens JF; Houssin R; Durant F; Hénichart JP
J Med Chem; 2004 Dec; 47(25):6195-206. PubMed ID: 15566290
[TBL] [Abstract][Full Text] [Related]
15. Designing selective COX-2 inhibitors: molecular modeling approaches.
Trummlitz G; van Ryn J
Curr Opin Drug Discov Devel; 2002 Jul; 5(4):550-61. PubMed ID: 12197313
[TBL] [Abstract][Full Text] [Related]
16. Genome wide analysis and comparative docking studies of new diaryl furan derivatives against human cyclooxygenase-2, lipoxygenase, thromboxane synthase and prostacyclin synthase enzymes involved in inflammatory pathway.
Sekhar PN; Reddy LA; De Maeyer M; Kumar KP; Srinivasulu YS; Sunitha MS; Sphoorthi IS; Jayasree G; Rao AM; Kothekar VS; Narayana PV; Kishor PB
J Mol Graph Model; 2009 Nov; 28(4):313-29. PubMed ID: 19766029
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
[TBL] [Abstract][Full Text] [Related]
18. Investigations concerning the COX/5-LOX inhibiting and hydroxyl radical scavenging potencies of novel 4,5-diaryl isoselenazoles.
Scholz M; Ulbrich HK; Dannhardt G
Eur J Med Chem; 2008 Jun; 43(6):1152-9. PubMed ID: 17976864
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological activity and molecular modeling studies of novel COX-1 inhibitors.
Martić M; Tatić I; Marković S; Kujundzić N; Kostrun S
Eur J Med Chem; 2004 Feb; 39(2):141-51. PubMed ID: 14987823
[TBL] [Abstract][Full Text] [Related]
20. Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example.
Rollinger JM; Haupt S; Stuppner H; Langer T
J Chem Inf Comput Sci; 2004; 44(2):480-8. PubMed ID: 15032527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
